Form 4: Marpai COO Scrip Increases Stake in Private Placement

Marpai, Inc.'s Chief Operating Officer, Dallas Scrip, acquired 100,000 shares of common stock and warrants for an additional 200,000 shares through a private placement.

Summary

• Dallas Scrip, Chief Operating Officer and 10% Owner of Marpai, Inc. (MRAI), reported a transaction.
• On November 7, 2025, Scrip purchased 100,000 shares of Class A Common Stock and common warrants to purchase up to 200,000 additional shares.
• The purchase was part of a private placement offering by Marpai Inc.
• The purchase price for each share of common stock and accompanying common warrant was $1.00.
• The common warrants have an exercise price of $1.00 per share, are immediately exercisable, and expire on November 6, 2028.
• The securities are held indirectly by the Dallas S. Scrip and Michelle R. Script Trust.

Sentiment

Score: 8

Explanation: The significant insider buying by the Chief Operating Officer, Dallas Scrip, through a private placement indicates strong confidence in the company's valuation and future prospects. This is generally viewed as a very positive signal by investors.

Positives

• Significant insider buying by the Chief Operating Officer, Dallas Scrip, indicates strong management confidence in Marpai, Inc.'s future.
• The acquisition of 100,000 shares of common stock and warrants for an additional 200,000 shares at a price of $1.00 per unit demonstrates a direct financial commitment.
• The warrants are immediately exercisable, providing flexibility for the insider to increase their direct ownership further.

Future Outlook

The common warrants acquired are exercisable immediately following the closing of the private placement offering and will remain exercisable for three years following the date of issuance, expiring on November 6, 2028.

Management Comments

• The Company entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock and common warrants to purchase up to 200,000 shares.

Industry Context

This insider transaction reflects a direct investment by a key executive, which is often interpreted by the market as a sign of confidence in the company's future prospects, irrespective of broader industry trends.

Comparison to Industry Standards

• Not applicable, as this filing details an individual insider transaction rather than company performance metrics that would typically be benchmarked against industry peers or global standards.

Related Party Transactions

• Dallas Scrip, Chief Operating Officer of Marpai, Inc., purchased securities directly from the company as part of a private placement offering.

Stakeholder Impact

• Shareholders: The transaction signals strong insider confidence, which could positively influence investor sentiment and potentially the stock price.
• Management: Dallas Scrip's increased stake aligns his personal financial interests more closely with the long-term success of the company.

Next Steps

• The common warrants can be exercised by Dallas Scrip at any time until their expiration on November 6, 2028.

Key Dates

Recommendation

The substantial insider buying by Marpai's Chief Operating Officer, Dallas Scrip, through a private placement offering is a strong positive signal. Insiders typically buy shares when they believe the stock is undervalued or that significant positive developments are on the horizon. This direct financial commitment, especially at a fixed price, suggests high confidence in the company's future performance and strategic direction, making it an attractive 'buy' signal for seasoned investors.

Keywords

Marpai Inc., MRAI, Dallas Scrip, Chief Operating Officer, Insider Buying, Private Placement, Common Stock, Warrants, SEC Form 4, Beneficial Ownership